Nasal & Sinus Decongestant Recalled for cGMP Deviations
Ultra Seal Corporation is voluntarily recalling Nasal & Sinus Decongestant packets containing phenylephrine HCl 5mg due to current good manufacturing practice (cGMP) deviations. The recall affects 3,508,200 packets distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II. The source text does not report any illnesses, injuries, or adverse events—only manufacturing practice deviations. Per the rubric, this is a moderate-severity voluntary precautionary recall with no reported harm.
Plain-English summary
Ultra Seal Corporation is voluntarily recalling Nasal & Sinus Decongestant (phenylephrine HCl 5mg, 2 tablets per packet) manufactured for Cintas First Aid & Safety due to cGMP deviations. The affected product was distributed nationwide within the United States.
The recalled lots include: AK9491 and AK9496 (expiration date 02/2022), and K9817 (expiration date 09/2022). A total of 3,508,200 packets are subject to this recall.
The recall was initiated on January 24, 2022, and classified by the FDA as Class II on January 31, 2022. Consumers who have purchased this product should discontinue use and contact the recalling firm or consult their healthcare provider with questions.
The recalled product
- Product
- Nasal & Sinus Decongestant (phenylephrine HCl 5mg) 2 tablets per packet, Mfd. for Cintas First Aid & Safety, Mason OH 45040
- Manufacturer
- Ultra Seal Corporation
- Category
- Drug — Oral decongestant
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: AK9491
- AK9496
- Exp. Date 02/2022
- K9817
- Exp. Date 09/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateTopCare Earwax Removal Kit Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22